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INTRODUCTION
Psoriasis is characterized by a variety of
changes in the skin, but the fundamental de-
fect that is responsible for the development
of the psoriatic lesion is still obscure, even
though the literature is full of announcements
of findings that are said to be specific. These
supposedly specific features have been of many
different types and have pointed at one time
or another toward every conceivable kind of
possible etiological mechanism. As time has
passed, however, every recognized attribute of
the disease has been found to be lacking in
absolute specificity.
Because of this lack of a definite feature, or
of a known etiological agent, psoriasis can be
defined only in terms of its usual manifesta-
tions: clinical, histological, physiological and
chemical. In other words, its recognition is
based upon probability. If enough of the at-
tributes usually exhibited by psoriatic lesions
are present, the probability reaches almost
100 percent.
Most studies of psoriasis have as their ul-
timate goal the identification of the cause or
causes of the disease. From this knowledge, an
understanding of the pathogenesis and the de-
velopment of rational treatment would follow
almost automatically. Intermediate goals are:
improvement of our understanding of the con-
ditions that lead to aggravation of the dis-
ease, improvement of our means of recogniz-
ing atypical eases, the discovery of means of
identification of individuals with latent psoria-
sis or with the potential to develop psoriasis, and
the deveelopment of improved methods of man-
agiag the disease.
The following observations, many of them
drawn from the experiences of the Psoriasis
Research Group in the Department of Derma-
tology at Stanford University, may serve to
clarify the position that we occupy today with
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respect to the ultimate goal. We should not be
surprised that the goal is not in sight. After
all, the amount of study of psoriasis is infini-
tesimal compared with that already directed
toward the solution of another growth disturb-
ance, cancer.
There have been a number of major ap-
proaches to the analysis of the psoriasis prob-
lem, each of which has permitted some specific
conclusions about the disease. Some of these
will be considered below.
NATURAL HI5TORY STUDY
Studies of the natural history of psoriasis
have been most important in the formulation
of the concept of psoriasis as a cbnieal en-
tity. One might think that this approach,
utilizing simple observation and correlation,
might have been exhausted long ago, but such
is not the ease, for the reason that newer de-
velopments have made possible much more ac-
curate and effective evaluation of data than
was employed prior to the introduction of
computer techniques. Furthermore, the dis-
ease is continually presenting itself under new
conditions. For example, rebound phenomena
have followed adrenal cortical suppression,
and exfoliation has been induced by chloro-
quine and other substances. Also, more data
are becoming available concerning special groups
of eases, such as those in particular racial cate-
gories or under special natural environmental
conditions.
In order to provide our research group with
facts, a detailed questionnaire was distributed
through our clinical group and by many co-
operating dermatologists in the United States.
Forty queries, relating to five broad areas in-
cluded: (1) characteristics of the psoriatic
participant and his family; (2) sites af-
fected by psoriasis; (3) the influence of vari-
ous physical factors; (4) relationships to other
diseases; and (5) the incidence and nature ol
spontaneous remissions. In 1966, when the
number of respondents reached 2144, the
questionnaires were coded by Dr. Ross Bright,
and a statistical analysis utilizing the IBM
7090 computer and the Harvard-developed
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FIG. 1. Age of onset of psoriasis among 2100 patients surveyed by our questionnaire
Data/Text System produced 700 cross-tabu- brothers and two nephews presented psoriatic
lated arrays. With the aid of the computer, lesions on the hands only.
our analyst has performed in minutes what
formerly took months to do with a desk cal- GENETIC FACTORS
culator. We respect the shortcomings of the The genetic aspect of psoriasis is one of
questionnaire as a measuring device; none- great importance. Most students of this dis-
theless, it provides quantitative data on a ease have no doubt that a genetic influence
large scale to give us guidelines for channeling exists in many eases, and presumably in all.
research efforts. The complete study is being The results of racial studies of psoriasis,
published elsewhere (1). such as those indicatiug that the disease is
An example of a contribution of this study infrequent in Negroes and in American In-
is the interesting observation that in 37 per- dians (2), while it is apparently absent among
cent of the participants in our survey pso- Indians of the undeveloped portions of Vene-
riasis had begun before the age of 20. In 12 zuela (3), are best explained on a genetic
percent the onset was prior to the age of 9. basis, although it is clear that the role of en-
An additional 24 percent reported the begin- vironmental factors, such as climate, diet and
ning of the psoriasis between the ages of 20 group habits has not been adequately exam-
and 29. This indicates, in contrast to the im- med in relation to differences of incidence of
pression created by some reports, that pso- psoriasis in racial groups. Our question-
riasis occurs frequently in the pre-adult age naire has not provided significant informa-
group. This is illustrated graphically in Fig. tion regarding racial incidence because more
I. At the same time, however, it is clear that than 98% of the patients studied were Cau-
many patients do not experience their first casian.
psoriatie plaque until middle age or later, so The strikingly increased incidence of pso-
estimates of the incidence of psoriasis must riasis in the progeny when both parents are
take into account the age of the individuals psoriatie as compared with that when only one
who are surveyed, parent is affected (4), is practically impos-
We plan to continue the questionnaire pro- sible to explain on any basis other than a
gram and initiate follow-up studies. Pursuit genetic one.
of more detailed information should answer a Our data indicate a strong familial mci-
number of important questions. One is con- dence of the disease, illustrated in Fig. 2.
cerned with whether there are familial pat- Eighteen percent of the respondents to our
terns of distribution of psoriasis. We have questionnaire reported a parent with pso-
already noted a family in which three riasis, 11% reported a sibling, and 13% iden-
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FAMILIAL INCIDENCE OF PSORIASIS
(2144 patients)
10% 8%
father mother
parents' brother
3% 11%
other
_______________ Pc/lent sbIingsrelatives '
sister
Fso. 2. Familial incidence of psoriasis related
by 2144patients with this disease.
tified more distant affected relatives. The in-
cidence of psoriasis in the children of the
respondents was only 3%, hut this figure is
misleadingly low because many of the children
in this group have not reached the age at
which psoriasis would be expected to appear. In
1956 a family that we studied presented only one
ease of psoriasis among five siblings. By 1961,
three of five had lesions of psoriasis.
We should like very much to find a specific
test for latent psoriasis, as this would be of
great value in making a genetic survey, and
indeed, without such a test, precise genetic
studies are not possible. Conclusions as to the
exact genetic mechanism, therefore, must re-
main tentative, although the evidence now
available satisfies us that psoriasis is an in-
heritable disease.
INDUCTION OF LESIONS
Whatever the exact genetic relationship, we
should remember that there are other substan-
tial factors that produce lesions of psoriasis,
and that these may be as important or even
more important than the genetic predisposi-
tion.
The most clear-cut inciting factor in psori-
asis is injury to the skin. The isomorphic re-
sponse, originally described by Heinrich
Koebner in 1877, could be produced by in-
tentionally injuring the skin in 23 of 25 se-
lected patients with active psoriasis studied
in our laboratories (5). Fourteen percent of
the respondents to onr questionnaire said that
their psoriatie lesions originally began at a
site of injury. These figures are doubtless low
inasmuch as certain types of injury might not
have been recognized by the patients. Any
kind of pre-existing skin lesion or minor
trauma to regions such as the elbows or knees,
may represent the initiator of an isomorphic
response. Several examples are shown in
Fig. 3.
A clear-cut deleterious effect upon the course
of psoriasis may be expected as a consequence
of systematically-administered steroid ther-
apy, and it is probable that many other chem-
ical substances excite or exaggerate the psori-
atic process, perhaps through some alteration
in the skin with a result comparable to a
Koebner reaction. Further experience is neces-
sary to evaluate the hazard of antimalarial
treatment reported by Ziprkowski et al (6). We
suspect that a large proportion of lesions of
psoriasis are initiated by some kind of local
injury to the skin.
With all of the assembled knowledge of this
isomorphic reaction, we are still in ignorance
of its fundamental nature. We do not even
know whether the first change in the skin is
epidermal or dermal, or both, since it is so
very difficult to produce an alteration on one
side of the basement membrane without dam-
aging elements on the other side. There is
need for further analysis of this response. In
the absence of this or any other manifesta-
tion of psoriasis in animals, the induced iso-
morphic response in man represents a valuable
model with which the evolution of the psori-
atic lesion can be studied under controlled con-
ditions.
Some other possible environmental factors in
the evolution of psoriatie lesions are suggested
from responses to our questionnaire. Seventy-
seven percent of the patients reported that they
were improved in hot weather and 88 percent
noted that they were worse in cold weather.
Seventy-eight percent specifically stated that
sunlight caused improvement, while 15 per-
cent reported exacerbation on exposure to sun-
light. Forty percent listed worry as a factor in
the exacerbation of psoriatic lesions. Of 362
women who had been pregnant since the on-
set of psoriasis, 50 percent reported an im-
provement in their skin lesions during preg-
nancy. The significance of this is not clear,
particularly since 27 percent noted exacerba-
tion during pregnancy.
REMiSSIONS OF PSORiASIS
As a counterpart to the induction of le-
sions of psoriasis, we should consider the re-
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Fm. 3. Induced psoriatic lesions. A. At the site of contact with a wrist watch. B. At the
site of repeated pressure of a pen on the hand of a student. C. Corresponding to the zone
of pressure and rubbing beneath the strap of a sandal. D. Beneath a brassiere strap, appar-
ently as a result of trauma.
mission of lesions. This may be spontaneous
or may be brought about by therapy.
38.5 percent of all individuals responding to
our inquiry reported that their psoriasis had
"disappeared completely" at some time during
the course of the disease. (Fig. 4) This mci-
deuce includes both spontaneous and induced
remissions. Remission occurred with almost
equal frequency in the two sexes. Several cor-
relations are interesting. Among individuals
who reported that sunlight improved their le-
sions, 81 percent reported "disappearance" of
D
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REMISSION OF PSOR lAStS
(Soil PATIENTS)
FIG. 4. Occurrence of complete remission re-
ported by 2011 patients with psoroasis.
the disease at some time, while among those
in whom sonlight made the condition
worse, there was only a 15 percent incidence of
"disappearance" of lesions. In patients who
had reported the development of psoriasis at
the site of an injury, only 14 percent noted
that the disease had ever "disappeared".
Women who indicated that they were better
during pregnancy, however, experienced no
greater incidence of complete remission than
did the total respondent group.
This phenomenon of complete remission,
even though in most patients it is only tem-
porary, tells something about the basic nature
of the disease, and its analysis may lead
toward the understanding of psoriasis. It is
likely, however, that it represents some altered
balance brought about, as in other diseases,
by external or internal changes that do not
modify the causal factors in any fundamental
way.
Complete remission of psoriatic lesions can
often be induced by therapy, but of all forms
of therapy known to us, none is a real cure.
Some or all lesions can be resolved with treat-
ment, such as application of tar and the use
of ultraviolet light, but plaques usually recur
at various intervals after treatment has been
discontinued. In spite of the new methods of
therapy involving topical application of ster-
oids or the administration of anti-metabo-
lites, the longest remissions still follow the
well-known Goeckcrman regime, utilizing tar
and ultraviolet light. This failure of any
therapy to effect a permanent cure emphasizes
the fact that the known therapeutic agents
achieve their success by inhibiting epidcrmal
growth, but not by removing the predisposi-
tion of the bkin to develop psoriatic plaques.
In view of the widening interest in the low
taurine diet for psoriasis as advocated origi-
nally by Roe (7), a report of the experience of
Zackhcim (8), in our group, is pertinent.
Taurine powder in gelatin capsules in a dose of
330 mg twice daily was given to each of ten
patients, for two to four weeks. This total
daily dosage of 660 mg is from five to ten times
the average daily ingestion of taurinc which is
present mainly in meat and sea food. The
psoriasis in these selected patients had been
relatively stable for several weeks. Only mild
local therapy such as weak coal tar or steroid
creams, or simple lubricating preparations
hod been used, and these were continued un-
changed during the taurine administration.
Each of seven patients ingested 660 mg daily
for four weeks and three others received the
same dose for two weeks. One of the patients
on taurine for four weeks became distinctly
worse. No significant change was noted in the
other nine patients. None of the patients ex-
perienced any marked pruritus.
The occurrence of worsening in one of ten
patients receiving a high dosage of taurine
in a two to four week period is probably not
significant. These findings, therefore, throw
doubt upon the hypothesis that taurine is of
etiological importance in psoriasis.
The relationship between psoriasis and
arthritis is a clear indication of the pres-
ence of a systemic component to psoriasis
even though there is no other recognized in-
ternal manifestation of the disease. Most in-
vestigators believe that "psoriatic arthritis"
differs from other forms of rheumatoid arthri-
tis (9) but the distinction is not sharp (10).
It might be hoped that something about the
nature of the associated arthritis would add to
the understanding of the nature of psoriasis,
but this prospect has not been realized either
by past studies or by our own analysis, which
does no more than support the view that the
relationship between psoriasis and arthritis is
more than incidental.
LABORATORY INVESTIGATIONS
A vast number of different measurements
hove been made of tissues and fluids from
patients with psoriosis. Certain measurable
abnormalities arc conspicuous, and over the
years there have been large numbers of re-
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ports suggesting that one or another finding is
specific for psoriasis, hut with the passage of
time the alleged specificity of such changes has
been proven wanting.
Without enumerating the more recent publi-
cations which claim specific changes in psori-
asis, most of which have not yet been ade-
quately tested for their validity, we predict
that their fate will be the same as that of the
many comparable claims that have preceded
them.
An example of difficulties that have con-
fused investigators in psoriasis is afforded by
the problems involved in the study of skin
lipids. Many workers have attributed special
significance to various changes that they iden-
tified in skin surface lipids from psoriatic
patients, and some have concluded that there is
a specific disturbance of hpid metabolism in
psoriasis (11). Wilkinson (12), in our labo-
ratories, (who has done meticulous work for
several years) has demonstrated that errors
relating to the collection of samples of surface
lipids arc very difficult to avoid, and that when
standard cleansing procedures and standard
time intervals for lipid accumulation precede
the collection, no significant abnormalities arc
found in lipids from the uninvolved skin of pa-
tients with psoriasis.
I should like to mention one study in our
laboratory by Dr. Marvin Karasek (13) that
was designed to serve as an indicator (Fig. 5)
of a wide variety of possible metabolic changes
that might characterize the psoriatic patient,
through preparing what has been called a
"metabolic profile" of the major constituents
of the blood in psoriatic patients.
Four classes of substances were separated by a
method based upon differences in the ionic
charge of the constituents. Each of the groups
was further resolved by gas chromatography
and paper chromatography for the separation
of the compounds indicated in Fig. 5. From
these data, he constructed a metabolic profile
for the steady state metabolism of the normal
control subject, and compared it with that ob-
tained from patients with psoriasis. The
psoriatic subjects used for this study were in
the basal state, ranged in age from 20 to 50,
and had moderate to severe psoriasis not un-
der treatment.
Thc normal profiles could not be distin-
guished from psoriatic profiles. From these
findings and from all other observations we
conclude that there is no major imbalance in
the overall metabolism of the psoriatic pa-
tient.
Another substantial negative effort by Kar-
asek and associates (13) was an attempt to
identify a possible viral etiology of psoriasis.
A large-scale screening process was initiated,
examining the scales, the feces, the blood, and
the urine of twenty patients with active
psoriasis. 100 ml. samples of blood were
drawn from each patient and concentrated by
ultraccntrifugation; 1000 ml. samples of 24
hour urine were similarly treated. Samples
were assayed for possible virus activity by
multiple passages in chick embryos (up to
six). The samples were screened in three cell
lines for cytopathic effects, and were inocu-
lated intraccrcbrally and intraporitoneally into
newborn mice. There was no cytopathic ef-
fect that could not be attributed to occasional
contaminating infections in the cultures, in-
cluding two instances of contamination by in-
fluenza virus. In addition, a labeled antibody
to inoculated embryonic tissue applied to
histological sections of frozen-dried psoriatic
tissue, failed to become localized in any ele-
ment of skin in lesions of psoriasis.
Karasek's group is still reluctant to con-
clude that viruses do not play a role in
psoriasis. They point out that had they
worked with cases of hepatitis with the same
techniques, their results would also have been
negative. They arc satisfied that they have not
missed a readily identified virus in psoriasis,
but feel that as more sophisticated approaches
become available from the massive screening
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Fm. 5. Result of a study of the serum "meta-
bolic profile" in psoriasis.
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HISTOCHEMISTRY—PSORIASIS EPIDERMIS
glycogen
amino acids
proteins
complex proteins
nucleic acids
phosphatases
_______________
dehydrogenases
DPN and TPN dependent
di a phora se s
Fm. 6. Summary of studies by histoehemieal
staining of psonatic plaques.
programs currently uscd for the possible viral
etiology of leukemia, another and more ex-
tensive search should be macIc applying these
new techniques.
Histoehemical changes in psoriasis have
been the subject of a large number of pub-
lished reports, and these will not be reviewed
here. Our own group (14) has made an ex-
tensive effort to confirm the presence of spe-
cific enzymatic or other histochemical changes
suggested by other workers. The result of our
studies, utilizing sections of quick-frozen or
frozen-dried psoriatic skin is stated briefly in
Fig. 6. In this area more than in most others,
published reports have suffered from the lack
of adequate controls. When hyperplastic epi-
dermis resulting from other causes has been
compared to psoriatic epidermis, we have
found without exception that similar devia-
tions from the normal histoehemical pattern
were present.
No discussion of psoriasis should be con-
cluded without a consideration of the signifi-
cance of the histological findings in the af-
fected skin. Changes in microscopical structure
of the skin in psoriasis are like the gross
manifestations of the disease: if they are char-
acteristic enough clinically, a diagnosis car-
ries a high degree of reliability. At the same
time, the histological structure of psoriatie
plaques lacks any absolutely distinctive qual-
ity. Not only are there differences in pattern
in different patients, but there may be differ-
ences within the same patient or changes in a
single lesion from one time to another. We
have seen many eases in which, following the
removal of a specimen presenting non-specific
changes, a subsequent biopsy yielded a fully
characteristic lesion. We have also obtained
"typical" and "atypical" lesions from the same
patient at the same time (15). In agreement
with the conclusion of Lagerholm (16), based
upon electron microscopical studies, we have
found that early lesions of psoriasis in gen-
eral possess a less characteristic appearance en
light microscopy than do older lesions. In our
experience a large number of psoriatic lesions
lack the fully characteristic histological ap-
pearance usually attributed to this disease.
Atypical lesions frequently present less epi-
dermal thickening than do well-developed,
classical psoriatie plaques (Fig. 7). Further-
more, they frequently do not contain the
greatly increased numbers of mitotic figures,
described in the specimens studied by Van
Scott (17), which led to an estimation of a
turnover time for psoriatie epidermis of about
four days. (Fig. 8) The fact that many psori-
atie plaques show significantly less histological
evidence of rapid epidermal growth should
warn us not to assume that all psoriatic epi-
Fm. 7. Variation in histological pattern in dif-
ferent lesions of psoriasis (X 45).
Different from
specific /0 50t-
iosis — thus far
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dermis possesses the degree of growth activity
estimated by Van Scott from the study of
"typical" lesions.
As a result of these observations, we believe
that the degree of growth alteration may be
different in different psoriatic lesions, even
when these are in the skin of a single in-
dividual. That the character of the epidermal
maturation in a single psoriatic lesion may
undergo rapid variation is suggested by the
sometimes striking alternation of parakera-
totic and orthokeratotic layers in the stratum
corneum over psoriatic plaques (Fig. 9). This
indicates qualitative differences in matura-
tion of the epidermis during successive time
periods corresponding to the formation of
these layers.
It should be recognized, however, that
changes in growth activity of the epidermis
in a psoriatic plaque need not represent a
fluctuating causal mechanism for the local
manifestation of the disease. Indeed, it seems
likely that the rapidly proliferating epidermis
in psoriasis is subject to superimposed con-
trolling factors that may change from time
to time. This concept provides an cxplana-
Ftc. 8. Difference in frequency of mitotic fig-
ures (arrows) in different lesions of psoriasis (X
250).
Ftc. 9. Alternation of orthokcratotic and parakeratotic portions of a psoriatic scale (X 85)
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tion for the success of a variety of therapeutic
agents in causing regression of lesions with-
out effecting a complete cure. We still believe
that the evidence of variability in the
growth activity of psoriatic lesions need not
detract in any way from the concept that the
psoriatic plaque is a result of a defect in nor-
mal epidermal growth control.
One further matter that should occupy our
attention is the question of whether any ab-
normality can he identified in uninvolved
skin of patients with psoriasis. That there is
something different in such skin is proved by
the occurence of the isomorphic reaction.
Ftc. 10. Result of 0.2% fluocinolone acetonide
cream applied topically to a psoriatic plaque. A.
Appearance before treatment. B. Appearance after
12 days of continuous topical therapy under an
occlusive dressing. The epidermis has been much
reduced in thickness hut the skin is not entirely
normal, exhibiting bulbous papillae that contain
unusually prominent capillaries (X 05).
Structural differences have been reported in
such skin (Braun-Falco) (18), and our own
studies have shown minor histological changes
in clinically uninvolved skin of some psori-
atic patients.
We have made an effort to determine
whether skin that has never been affected with
visible lesions has been altered. This is diffi-
cult because the memory of patients is often
faulty. When we have been sure that psori-
asis has never affected the area of clinically un-
involved skin we have not found any histologi-
cal abnormalities. It is our conclusion that
when recognizable structural changes have
been present in clinically uninvolved skin,
they have represented residual changes due to
prior active lesions comparable to those after
resolution of psoriatic lesions following topi-
cal fluocinolone application (Fig. 10) or after
triamcinolone injection (Komisaruk, et al.)
(19).
A PnOBABLE PATHOGENIC r,EcHANI5M
IN PsORlAsis
There is widespread agreement that the
process leading to the appearance of a psori-
atic plaque is cpidcrmal hyperplasia, and that
without this, the plaque would not appear.
A fundamental aspect of the pathogenesis,
therefore, is the cause of this abnormal growth.
Based upon the lack of identification of any
constant difference between psoriatic epider-
mis and other kinds of hyperplastic epidermis,
we conclude that the cpidcrmal growth in
psoriasis is not in itself distinctive, but that
a modification of growth control is probably
the underlying mechanism. The growth rate in
psoriatic epidermis appears to be no greater
than that which can be achieved in a healing
wound or in cell culture.
It should be kept in mind that normal epi-
dcrmal cells have a capacity for rapid growth,
that is displayed quickly after the epidermis
is injured. The normal epidermis, therefore,
represents a state of great restriction of
growth potential. It is possible that there arc
growth stimulating substances that act even
in the presence of the normal inhibitors, but
none has been identified in psoriatic plaques,
and it appears probable that the hyperplasia
comes about largely through the reduction or
loss of the normal control mechanism.
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CONCLUSIONS
Clinical and laboratory studies have reached
almost complete agreement supporting the fol-
lowing conclusions:
1. That there is no specific morphologic or
physiologic marker which by itself can
identify psoriasis. It is possible, of
course, that further study will disclose a
distinctive change but it is more likely
that the nature of the tissue reaction is
non-specific, suggesting that the basic ab-
normality lies not in the nature of the
growing cells, but in an alteration of the
mechanism of epidcrmal growth con-
trol.
2. That no metabolic change in the patient
or chemical peculiarity of the growing
epidermis in psoriasis distinguishes it
from other types of actively growing epi-
dermis. This is in accord with morpho-
logical and physiological findings. It
seems likely, however, that some significant
chemical change may still be identified, par-
ticularly one that relates to growth
control rather than to the growth process
itself. By chemical change, one includes
enzymatic processes, hormonal influences,
and effects of undiscovered infectious
agents.
It is a normal stage in the evolution of
understanding a disease for many conflicting
views to be promoted. This simply means
that many people are thinking about a prob-
lem that has been with us for a long time.
We should remember the confusion concerning
leprosy that existed before the Mycobacterium
ieproe was discovered, or the uncertainty re-
lated to systemic lupus crythematosus before
the concept of hypersensitivity was applied,
or the number of suggested causes of pellagra
before this was recognized as a vitamin de-
ficiency disease!
There is encouraging progress in the study
of psoriasis, and if we join our forces there
will be a much better chance to solve the
problem cf this challenging disease.
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